United States Biotechnology & Medical Research

Eloxx Pharmaceuticals Inc (ELOX)

Track

Eloxx Pharmaceuticals Inc. has recorded no insider trading activity within the last three months. The most recent transaction occurred on November 29, 2021, when an interim executive purchased shares. Prior to that, significant buying activity by multiple insiders was observed throughout May 2021 and June 2019.
Ticker: ELOX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eloxx Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Geffken Daniel E.
INTERIM CFO
1 purchase — total 36,000 USD
Buy 29 Nov 2021
Value US$911,445.00 | Price 51.09 | Shares 18,606
Buy 13 May 2021
Value US$2,575,580.02 | Price 151.67 | Shares 95,606
Buy 13 May 2021
Value US$3,901,962.71 | Price 199.42 | Shares 71,111
Buy 13 May 2021
Value US$3,551,157.45 | Price 1.35 | Shares 2,630,487
Buy 13 May 2021
Value US$1,728,842.40 | Price 1.35 | Shares 1,280,624
Buy 13 May 2021
Value US$799,999.20 | Price 1.35 | Shares 592,592
Buy 13 May 2021
Value US$1,919,999.70 | Price 1.35 | Shares 1,422,222
Buy 13 May 2021
Value US$3,551,157.45 | Price 1.35 | Shares 2,630,487
Buy 13 May 2021
Value US$1,728,842.40 | Price 1.35 | Shares 1,280,624
Buy 13 May 2021
Value US$3,215,551.50 | Price 1.35 | Shares 2,381,890
Buy 13 May 2021
Value US$114,447.60 | Price 1.35 | Shares 84,776
Buy 24 Jun 2019
Value US$216,000.00 | Price 9.00 | Shares 24,000
Buy 24 Jun 2019
Value US$422,397.00 | Price 9.00 | Shares 46,933
Buy 24 Jun 2019
Value US$781,254.00 | Price 9.00 | Shares 86,806
Buy 24 Jun 2019
Value US$380,349.00 | Price 9.00 | Shares 42,261
Buy 24 Jun 2019
Value US$216,000.00 | Price 9.00 | Shares 24,000
Buy 24 Jun 2019
Value US$422,397.00 | Price 9.00 | Shares 46,933
Buy 24 Jun 2019
Value US$781,254.00 | Price 9.00 | Shares 86,806
Buy 24 Jun 2019
Value US$380,349.00 | Price 9.00 | Shares 42,261
Buy 24 Jun 2019
Value US$216,000.00 | Price 9.00 | Shares 24,000
Buy 24 Jun 2019
Value US$422,397.00 | Price 9.00 | Shares 46,933
Buy 24 Jun 2019
Value US$781,254.00 | Price 9.00 | Shares 86,806
Buy 24 Jun 2019
Value US$380,349.00 | Price 9.00 | Shares 42,261
Buy 22 May 2018
Value US$71,700.00 | Price 14.34 | Shares 5,000
Buy 30 Apr 2018
Value US$909,996.75 | Price 9.75 | Shares 93,333
Buy 30 Apr 2018
Value US$1,683,103.50 | Price 9.75 | Shares 172,626
Buy 30 Apr 2018
Value US$819,399.75 | Price 9.75 | Shares 84,041
Buy 30 Apr 2018
Value US$909,996.75 | Price 9.75 | Shares 93,333
Buy 30 Apr 2018
Value US$1,683,103.50 | Price 9.75 | Shares 172,626
Buy 30 Apr 2018
Value US$819,399.75 | Price 9.75 | Shares 84,041
Buy 30 Apr 2018
Value US$731,250.00 | Price 9.75 | Shares 75,000
Buy 30 Apr 2018
Value US$909,996.75 | Price 9.75 | Shares 93,333
Buy 30 Apr 2018
Value US$1,683,103.50 | Price 9.75 | Shares 172,626
Buy 30 Apr 2018
Value US$819,399.75 | Price 9.75 | Shares 84,041
Buy 30 Apr 2018
Value US$2,925,000.00 | Price 9.75 | Shares 300,000
Buy 4 Apr 2018
Value US$24,908.00 | Price 9.58 | Shares 2,600
Buy 3 Apr 2018
Value US$53,637.00 | Price 9.41 | Shares 5,700
Buy 29 Mar 2018
Value US$43,380.00 | Price 9.64 | Shares 4,500
Buy 26 Mar 2018
Value US$18,980.00 | Price 9.49 | Shares 2,000
Buy 23 Mar 2018
Value US$38,520.00 | Price 8.56 | Shares 4,500
Buy 23 Mar 2018
Value US$89,900.00 | Price 8.99 | Shares 10,000
Buy 22 Mar 2018
Value US$12,800.00 | Price 8.00 | Shares 1,600
Buy 22 Mar 2018
Value US$23,672.00 | Price 8.00 | Shares 2,959
Buy 22 Mar 2018
Value US$11,528.00 | Price 8.00 | Shares 1,441
Buy 22 Mar 2018
Value US$12,800.00 | Price 8.00 | Shares 1,600
Buy 22 Mar 2018
Value US$23,672.00 | Price 8.00 | Shares 2,959
Buy 22 Mar 2018
Value US$11,528.00 | Price 8.00 | Shares 1,441
Buy 22 Mar 2018
Value US$12,800.00 | Price 8.00 | Shares 1,600
Buy 22 Mar 2018
Value US$23,672.00 | Price 8.00 | Shares 2,959
Buy 22 Mar 2018
Value US$11,528.00 | Price 8.00 | Shares 1,441
Buy 21 Mar 2018
Value US$13,288.00 | Price 7.55 | Shares 1,760
Buy 21 Mar 2018
Value US$24,575.25 | Price 7.55 | Shares 3,255
Buy 21 Mar 2018
Value US$11,966.75 | Price 7.55 | Shares 1,585
Buy 21 Mar 2018
Value US$13,288.00 | Price 7.55 | Shares 1,760
Buy 21 Mar 2018
Value US$24,575.25 | Price 7.55 | Shares 3,255
Buy 21 Mar 2018
Value US$11,966.75 | Price 7.55 | Shares 1,585
Buy 21 Mar 2018
Value US$13,288.00 | Price 7.55 | Shares 1,760
Buy 21 Mar 2018
Value US$24,575.25 | Price 7.55 | Shares 3,255
Buy 21 Mar 2018
Value US$11,966.75 | Price 7.55 | Shares 1,585
Buy 21 Mar 2018
Value US$1,998.80 | Price 7.60 | Shares 263
Buy 29 Sep 2015
Value US$21,350.00 | Price 0.61 | Shares 35,000
Buy 19 Dec 2013
Value US$3,320.00 | Price 4.15 | Shares 800
Buy 20 May 2013
Value US$1,200.00 | Price 0.04 | Shares 30,000
Buy 26 Nov 2012
Value US$400.00 | Price 0.16 | Shares 2,500
Buy 21 Nov 2012
Value US$5,890.00 | Price 0.16 | Shares 38,000
Buy 29 Mar 2012
Value US$2,600.00 | Price 0.26 | Shares 10,000
Buy 6 Jan 2012
Value US$50,000.08 | Price 0.26 | Shares 192,308
Buy 6 Jan 2012
Value US$249,999.88 | Price 0.26 | Shares 961,538
Buy 7 Dec 2011
Value US$10,402.01 | Price 0.24 | Shares 44,039
Buy 13 Jun 2011
Value US$5,400.00 | Price 0.27 | Shares 20,000
Buy 22 Mar 2011
Value US$4,191.00 | Price 0.28 | Shares 15,000
Buy 21 Mar 2011
Value US$804.90 | Price 0.27 | Shares 3,000
Buy 24 Feb 2011
Value US$865.20 | Price 0.29 | Shares 3,000
Buy 23 Feb 2011
Value US$856.50 | Price 0.29 | Shares 3,000
Buy 25 May 2010
Value US$2,440.88 | Price 0.52 | Shares 4,694
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-01 2021-11-29 B Purchase
1.4
Geffken Daniel E.

INTERIM CFO

Officer
18,606 -0.1%
51.09
US$911,445 		18,606 -0.1% 51.09 US$911,445
2021-05-17 2021-05-13 B Purchase
0.6
Kariv Tomer
Non-Executive Director
95,606 -48.3%
151.67
US$2,575,580 		95,606 -48.3% 151.67 US$2,575,580
2021-05-17 2021-05-13 B Purchase
0.6
Kariv Tomer
Non-Executive Director
71,111 +45.4%
199.42
US$3,901,963 		71,111 +45.4% 199.42 US$3,901,963
2021-05-17 2021-05-13 B Purchase
0.6
Kariv Tomer
Non-Executive Director
2,630,487 +250.7%
1.35
US$3,551,157 		2,630,487 +250.7% 1.35 US$3,551,157
2021-05-17 2021-05-13 B Purchase
0.6
Kariv Tomer
Non-Executive Director
1,280,624 +250.7%
1.35
US$1,728,842 		1,280,624 +250.7% 1.35 US$1,728,842
2021-05-17 2021-05-13 B Purchase
0.6
Nussbaum Ran
Non-Executive Director
592,592 +2469.1%
1.35
US$799,999 		592,592 +2469.1% 1.35 US$799,999
2021-05-17 2021-05-13 B Purchase
0.6
Nussbaum Ran
Non-Executive Director
1,422,222 +250.7%
1.35
US$1,920,000 		1,422,222 +250.7% 1.35 US$1,920,000
2021-05-17 2021-05-13 B Purchase
0.6
Nussbaum Ran
Non-Executive Director
2,630,487 +250.7%
1.35
US$3,551,157 		2,630,487 +250.7% 1.35 US$3,551,157
2021-05-17 2021-05-13 B Purchase
0.6
Nussbaum Ran
Non-Executive Director
1,280,624 +250.7%
1.35
US$1,728,842 		1,280,624 +250.7% 1.35 US$1,728,842
2021-05-17 2021-05-13 B Purchase
PAREKH RAJESH B
Non-Executive Director
2,381,890 +97.4%
1.35
US$3,215,552 		2,381,890 +97.4% 1.35 US$3,215,552
2021-05-17 2021-05-13 B Purchase
PAREKH RAJESH B
Non-Executive Director
84,776 +97.4%
1.35
US$114,448 		84,776 +97.4% 1.35 US$114,448
2019-06-26 2019-06-24 B Purchase
0.6
Kariv Tomer
24,000 +inf%
9.00
US$216,000 		24,000 +inf% 9.00 US$216,000
2019-06-26 2019-06-24 B Purchase
0.6
Kariv Tomer
46,933 +9.0%
9.00
US$422,397 		46,933 +9.0% 9.00 US$422,397
2019-06-26 2019-06-24 B Purchase
0.6
Kariv Tomer
86,806 +9.0%
9.00
US$781,254 		86,806 +9.0% 9.00 US$781,254
2019-06-26 2019-06-24 B Purchase
0.6
Kariv Tomer
42,261 +9.0%
9.00
US$380,349 		42,261 +9.0% 9.00 US$380,349
2019-06-26 2019-06-24 B Purchase
0.6
Pontifax Management 4 G.P. (2015) Ltd.
Large shareholder
24,000 +inf%
9.00
US$216,000 		24,000 +inf% 9.00 US$216,000
2019-06-26 2019-06-24 B Purchase
0.6
Pontifax Management 4 G.P. (2015) Ltd.
Large shareholder
46,933 +9.0%
9.00
US$422,397 		46,933 +9.0% 9.00 US$422,397
2019-06-26 2019-06-24 B Purchase
0.6
Pontifax Management 4 G.P. (2015) Ltd.
Large shareholder
86,806 +9.0%
9.00
US$781,254 		86,806 +9.0% 9.00 US$781,254
2019-06-26 2019-06-24 B Purchase
0.6
Pontifax Management 4 G.P. (2015) Ltd.
Large shareholder
42,261 +9.0%
9.00
US$380,349 		42,261 +9.0% 9.00 US$380,349
2019-06-26 2019-06-24 B Purchase
0.6
Nussbaum Ran
24,000 +inf%
9.00
US$216,000 		24,000 +inf% 9.00 US$216,000
2019-06-26 2019-06-24 B Purchase
0.6
Nussbaum Ran
46,933 +9.0%
9.00
US$422,397 		46,933 +9.0% 9.00 US$422,397
2019-06-26 2019-06-24 B Purchase
0.6
Nussbaum Ran
86,806 +9.0%
9.00
US$781,254 		86,806 +9.0% 9.00 US$781,254
2019-06-26 2019-06-24 B Purchase
0.6
Nussbaum Ran
42,261 +9.0%
9.00
US$380,349 		42,261 +9.0% 9.00 US$380,349
2018-05-23 2018-05-22 B Purchase Ward Robert

Chief Executive Officer

Executive Director
5,000 +50.0%
14.34
US$71,700 		5,000 +50.0% 14.34 US$71,700
2018-05-01 2018-04-30 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
93,333 +21.9%
9.75
US$909,997 		93,333 +21.9% 9.75 US$909,997
2018-05-01 2018-04-30 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
172,626 +21.9%
9.75
US$1,683,104 		172,626 +21.9% 9.75 US$1,683,104
2018-05-01 2018-04-30 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
84,041 +21.9%
9.75
US$819,400 		84,041 +21.9% 9.75 US$819,400
2018-05-01 2018-04-30 B Purchase Nussbaum Ran Non-Executive Director
93,333 +21.9%
9.75
US$909,997 		93,333 +21.9% 9.75 US$909,997
2018-05-01 2018-04-30 B Purchase Nussbaum Ran Non-Executive Director
172,626 +21.9%
9.75
US$1,683,104 		172,626 +21.9% 9.75 US$1,683,104
2018-05-01 2018-04-30 B Purchase Nussbaum Ran Non-Executive Director
84,041 +21.9%
9.75
US$819,400 		84,041 +21.9% 9.75 US$819,400
2018-05-01 2018-04-30 B Purchase Shabtai Gilad Large shareholder
75,000 +2.3%
9.75
US$731,250 		75,000 +2.3% 9.75 US$731,250
2018-05-01 2018-04-30 B Purchase Kariv Tomer Non-Executive Director
93,333 +21.9%
9.75
US$909,997 		93,333 +21.9% 9.75 US$909,997
2018-05-01 2018-04-30 B Purchase Kariv Tomer Non-Executive Director
172,626 +21.9%
9.75
US$1,683,104 		172,626 +21.9% 9.75 US$1,683,104
2018-05-01 2018-04-30 B Purchase Kariv Tomer Non-Executive Director
84,041 +21.9%
9.75
US$819,400 		84,041 +21.9% 9.75 US$819,400
2018-05-01 2018-04-30 B Purchase Kleijwegt Martijn Non-Executive Director
300,000 +11.3%
9.75
US$2,925,000 		300,000 +11.3% 9.75 US$2,925,000
2018-04-05 2018-04-04 B Purchase Shabtai Gilad Large shareholder
2,600 +0.1%
9.58
US$24,908 		2,600 +0.1% 9.58 US$24,908
2018-04-05 2018-04-03 B Purchase Shabtai Gilad Large shareholder
5,700 +0.2%
9.41
US$53,637 		5,700 +0.2% 9.41 US$53,637
2018-04-02 2018-03-29 B Purchase Shabtai Gilad Large shareholder
4,500 +0.1%
9.64
US$43,380 		4,500 +0.1% 9.64 US$43,380
2018-03-28 2018-03-26 B Purchase Avnur Zafrira
2,000 +760.5%
9.49
US$18,980 		2,000 +760.5% 9.49 US$18,980
2018-03-26 2018-03-23 B Purchase WEAVER GREGORY L

Chief Financial Officer
4,500 +inf%
8.56
US$38,520 		4,500 +inf% 8.56 US$38,520
2018-03-26 2018-03-23 B Purchase Ward Robert

Chief Executive Officer

Executive Director
10,000 +inf%
8.99
US$89,900 		10,000 +inf% 8.99 US$89,900
2018-03-23 2018-03-22 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
1,600 +0.4%
8.00
US$12,800 		1,600 +0.4% 8.00 US$12,800
2018-03-23 2018-03-22 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
2,959 +0.4%
8.00
US$23,672 		2,959 +0.4% 8.00 US$23,672
2018-03-23 2018-03-22 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
1,441 +0.4%
8.00
US$11,528 		1,441 +0.4% 8.00 US$11,528
2018-03-23 2018-03-22 B Purchase Kariv Tomer
1,600 +0.4%
8.00
US$12,800 		1,600 +0.4% 8.00 US$12,800
2018-03-23 2018-03-22 B Purchase Kariv Tomer
2,959 +0.4%
8.00
US$23,672 		2,959 +0.4% 8.00 US$23,672
2018-03-23 2018-03-22 B Purchase Kariv Tomer
1,441 +0.4%
8.00
US$11,528 		1,441 +0.4% 8.00 US$11,528
2018-03-23 2018-03-22 B Purchase Nussbaum Ran
1,600 +0.4%
8.00
US$12,800 		1,600 +0.4% 8.00 US$12,800
2018-03-23 2018-03-22 B Purchase Nussbaum Ran
2,959 +0.4%
8.00
US$23,672 		2,959 +0.4% 8.00 US$23,672
2018-03-23 2018-03-22 B Purchase Nussbaum Ran
1,441 +0.4%
8.00
US$11,528 		1,441 +0.4% 8.00 US$11,528
2018-03-23 2018-03-21 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
1,760 +0.4%
7.55
US$13,288 		1,760 +0.4% 7.55 US$13,288
2018-03-23 2018-03-21 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
3,255 +0.4%
7.55
US$24,575 		3,255 +0.4% 7.55 US$24,575
2018-03-23 2018-03-21 B Purchase Pontifax Management 4 G.P. (2015) Ltd. Large shareholder
1,585 +0.4%
7.55
US$11,967 		1,585 +0.4% 7.55 US$11,967
2018-03-23 2018-03-21 B Purchase Kariv Tomer
1,760 +0.4%
7.55
US$13,288 		1,760 +0.4% 7.55 US$13,288
2018-03-23 2018-03-21 B Purchase Kariv Tomer
3,255 +0.4%
7.55
US$24,575 		3,255 +0.4% 7.55 US$24,575
2018-03-23 2018-03-21 B Purchase Kariv Tomer
1,585 +0.4%
7.55
US$11,967 		1,585 +0.4% 7.55 US$11,967
2018-03-23 2018-03-21 B Purchase Nussbaum Ran
1,760 +0.4%
7.55
US$13,288 		1,760 +0.4% 7.55 US$13,288
2018-03-23 2018-03-21 B Purchase Nussbaum Ran
3,255 +0.4%
7.55
US$24,575 		3,255 +0.4% 7.55 US$24,575
2018-03-23 2018-03-21 B Purchase Nussbaum Ran
1,585 +0.4%
7.55
US$11,967 		1,585 +0.4% 7.55 US$11,967
2018-03-22 2018-03-21 B Purchase Avnur Zafrira
263 +inf%
7.60
US$1,999 		263 +inf% 7.60 US$1,999
2015-10-01 2015-09-29 B Purchase FROST PHILLIP MD ET AL Non-Executive Director Large shareholder
35,000 +2.2%
0.61
US$21,350 		35,000 +2.2% 0.61 US$21,350
2013-12-20 2013-12-19 B Purchase Browne Leslie J

President and CEO

Executive Director
800 +163.3%
4.15
US$3,320 		800 +163.3% 4.15 US$3,320
2013-05-21 2013-05-20 B Purchase Browne Leslie J

President and CEO

Executive Director
30,000 +157.9%
0.04
US$1,200 		30,000 +157.9% 0.04 US$1,200
2012-11-26 2012-11-26 B Purchase FORBES CHRISTOPHER Non-Executive Director Large shareholder
2,500 +0.0%
0.16
US$400 		2,500 +0.0% 0.16 US$400
2012-11-26 2012-11-21 B Purchase RECTOR DAVID Non-Executive Director
38,000 +12.1%
0.16
US$5,890 		38,000 +12.1% 0.16 US$5,890
2012-03-30 2012-03-29 B Purchase Browne Leslie J

President and CEO

Officer
10,000 +111.1%
0.26
US$2,600 		10,000 +111.1% 0.26 US$2,600
2012-01-19 2012-01-06 B Purchase FORBES CHRISTOPHER Non-Executive Director Large shareholder
192,308 +2.4%
0.26
US$50,000 		192,308 +2.4% 0.26 US$50,000
2012-01-19 2012-01-06 B Purchase Waksal Harlan Non-Executive Director
961,538 +102.2%
0.26
US$250,000 		961,538 +102.2% 0.26 US$250,000
2011-12-08 2011-12-07 B Purchase RECTOR DAVID Non-Executive Director
44,039 +16.3%
0.24
US$10,402 		44,039 +16.3% 0.24 US$10,402
2011-06-14 2011-06-13 B Purchase RECTOR DAVID Non-Executive Director
20,000 +8.0%
0.27
US$5,400 		20,000 +8.0% 0.27 US$5,400
2011-03-23 2011-03-22 B Purchase FORBES CHRISTOPHER Non-Executive Director Large shareholder
15,000 +0.2%
0.28
US$4,191 		15,000 +0.2% 0.28 US$4,191
2011-03-22 2011-03-21 B Purchase Browne Leslie J

President and CEO

Executive Director
3,000 +50.0%
0.27
US$805 		3,000 +50.0% 0.27 US$805
2011-02-24 2011-02-24 B Purchase Browne Leslie J

President and CEO

Officer
3,000 +100.0%
0.29
US$865 		3,000 +100.0% 0.29 US$865
2011-02-24 2011-02-23 B Purchase Browne Leslie J

President and CEO

Officer
3,000 +inf%
0.29
US$856 		3,000 +inf% 0.29 US$856
2010-05-27 2010-05-25 B Purchase RECTOR DAVID Non-Executive Director
4,694 +1.9%
0.52
US$2,441 		4,694 +1.9% 0.52 US$2,441
Explore more

More insider trading research around Eloxx Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America